These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14508831)

  • 1. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma.
    Boonla C; Wongkham S; Sheehan JK; Wongkham C; Bhudhisawasdi V; Tepsiri N; Pairojkul C
    Cancer; 2003 Oct; 98(7):1438-43. PubMed ID: 14508831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
    Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
    Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
    J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma.
    Wongkham S; Sheehan JK; Boonla C; Patrakitkomjorn S; Howard M; Kirkham S; Sripa B; Wongkham C; Bhudhisawasdi V
    Cancer Lett; 2003 May; 195(1):93-9. PubMed ID: 12767517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance.
    Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC
    Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear survivin expression predicts poor outcome in cholangiocarcinoma.
    Javle MM; Tan D; Yu J; LeVea CM; Li F; Kuvshinoff BW; Gibbs JF
    Hepatogastroenterology; 2004; 51(60):1653-7. PubMed ID: 15532797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of MUC mucin in cholangiocarcinoma.
    Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
    Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.
    Boonla C; Sripa B; Thuwajit P; Cha-On U; Puapairoj A; Miwa M; Wongkham S
    World J Gastroenterol; 2005 Aug; 11(32):4939-46. PubMed ID: 16124042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
    Paik KY; Jung JC; Heo JS; Choi SH; Choi DW; Kim YI
    J Gastroenterol Hepatol; 2008 May; 23(5):766-70. PubMed ID: 17868336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.